1-Phenylcyclobutanamine Hydrochloride is primarily used in research and development within the pharmaceutical industry. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting the central nervous system. Its structure is often explored for potential applications in the development of antidepressants, anxiolytics, and other neuropsychiatric medications. Additionally, it is utilized in studies investigating receptor binding and modulation, helping to advance the understanding of neurological pathways and drug mechanisms. Its role in organic synthesis also extends to the creation of novel compounds with potential therapeutic properties.